All stocks / NSTM
NovelStem International Corp. NSTM
NovelStem International (NSTM): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- NOVELSTEM INTERNATIONAL CORP
- Market tier
- OTC Pink Limited
- Trading status
- Active
- Last trade
- Nov 10
The financial report, and what it means
Annual figures to 2025-12-31- Net income
- $2,379,882
It earned more than it spent
SteadyAfter all costs, the company kept $2.4 million as profit in the year.
- Cash and cash equivalents
- $333
- Net cash used in operating activities
- ($167,633)
The cash could run out soon
Under strainIt had $333 in the bank and used about $13,969 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.
- Total assets
- $15,786
- Total liabilities
- $2,157,441
It owes more than it owns
Under strainEverything the company owns adds up to $15,786. Its debts and unpaid bills add up to $2.2 million. That is about $136.67 owed for every $1 owned.
What this adds up to
2 of 3 checks show strain. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 49,332,455 shares as of 2026-11-16: 49,332,455 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about NSTM
Does NSTM file reports with the SEC?
Yes. NovelStem International files with the SEC under company number 0000912544. The most recent filing we hold is a 10-Q dated 2026-11-16.
Source recordHow many NSTM shares are outstanding?
49,332,455 shares as of 2026-11-16, as reported to the SEC.
Source recordHas NSTM filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Is NovelStem International making money?
After all costs, the company kept $2.4 million as profit in the year. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record